Retrospective Review of Norethindrone Use in Adolescents
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
This retrospective review examined the efficacy and safety of norethindrone in adolescent patients.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Study objectiveOur objectives were to review norethindrone use in an adolescent population in a tertiary care center and to assess the effectiveness of the norethindrone taper in the management of acute heavy menstrual bleeding in adolescents.DesignRetrospective cohort study.SettingTertiary care center.Participants176 adolescent females prescribed norethindrone 0.35 mg between July 2007 and September 2010.InterventionsNone.Main outcome measuresDiscontinuation and irregular bleeding rates.ResultsMean age was 14.8 ± 2.3 years. Most common indication for use was heavy menstrual bleeding (32.9%). Most common reasons for use of a progestin only pill were neurologic (27.8%) and cardiovascular diseases (17.6%). Discontinuation rate was 48.5%, most commonly for irregular bleeding (54.5%). Irregular bleeding and systemic side effects were associated with discontinuation (P = .006 and .003 respectively). No serious adverse events were reported. Twenty patients required norethindrone taper for heavy bleeding; of this group 78.9% experienced complete cessation of bleeding within 7 days.ConclusionsOur findings support use of norethindrone as an effective alternative among adolescents with contraindications to administration of estrogen and for whom control of acute heavy menstrual bleeding is desired.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- 6 Dysfunctional uterine bleeding 1989
- The use of newer progestins for contraception 2010
- High‐Dose Medroxyprogesterone Acetate for the Treatment of Dysfunctional Uterine Bleeding in 24 Adolescents 1997
Cited by (1)
References (26)
- 6 Dysfunctional uterine bleeding via openalex
- High‐Dose Medroxyprogesterone Acetate for the Treatment of Dysfunctional Uterine Bleeding in 24 Adolescents via openalex
- The use of newer progestins for contraception via openalex
- W162320222 via openalex
- W1473042446 via openalex
- doi:10.1097/01.aog.0000238343.62063.22 via openalex
- doi:10.1093/humupd/dmb025 via openalex
- doi:10.1016/0010-7824(94)90118-x via openalex
- doi:10.4183/aeb.2005.240 via openalex
- doi:10.15585/mmwr.rr6503a1 via openalex
- doi:10.1016/0010-7824(90)90077-9 via openalex
- doi:10.1002/14651858.cd007541.pub3 via openalex
- doi:10.2217/whe.10.36 via openalex
- doi:10.1159/isbn.978-3-318-01011-4 via openalex
- W2461381067 via openalex
- doi:10.1111/j.1745-7599.2009.00473.x via openalex
- W6601473286 via openalex
- W6606674239 via openalex
- W6628521659 via openalex
- W6682017285 via openalex
- doi:10.1002/14651858.cd007541 via openalex
- doi:10.1016/0010-7824(94)90119-8 via openalex
- doi:10.1089/jwh.2011.2851 via openalex
- doi:10.1185/03007995.2010.493088 via openalex
- doi:10.1097/00008480-199608000-00005 via openalex
- doi:10.1016/j.jpag.2009.02.005 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T06:37:04.871248+00:00
- unpaywall
- last seen: 2026-09-07T06:27:18.705824+00:00
License: CC0
· commercial use OK